Market revenue in 2023 | USD 2,054.7 million |
Market revenue in 2030 | USD 5,797.9 million |
Growth rate | 16% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 74.44% in 2023. Horizon Databook has segmented the India precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
In India, PM is in the nascent stage; however, it is practiced in several specialties, such as cardiology, oncology, diabetology, and psychiatry. PM has gained significant ground in India, especially in the field of oncology. With a diverse population, India has a unique and pressing need for personalized medicine.
Cardio-metabolic diseases, infectious diseases, rare genetic disorders, and cancer are the priority areas where PM can make the most significant impact. With India’s booming biotechnology sector, several home-grown companies are entering the PM research area. Thus, these factors are anticipated to primarily drive the precision medicine market in India over the forecast period.
Furthermore, organizations in the country are undertaking initiatives to ensure that professionals are aware of the new genomic technologies in the market. For instance, Genomics India is heavily invested in the development of personalized diagnostics, genomics for healthcare, and genomics & data analytics.
Horizon Databook provides a detailed overview of country-level data and insights on the India precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into India precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account